No shortage on file

DAXAS

ASTRAZENECA CANADA INC

Quick answers

Is there a shortage of DAXAS in Canada?

No. There is no current shortage of DAXAS 500MCG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ZORYVE

ARCUTIS CANADA, INC.

0.05% · DIN 02570793

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DIN

02359456

Strength

500MCG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ROFLUMILAST

See all ROFLUMILAST products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2025-08-11

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from ASTRAZENECA CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

20MG · DIN 02236606

1MG · DIN 02224135

DIN 02518058

0.5MG · DIN 00786616

60MG · DIN 02455005

90MG · DIN 02368544